TY - JOUR T1 - Single-cell RNA-seq reveals profound monocyte changes in Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 infection (PIMS-TS) JF - medRxiv DO - 10.1101/2020.08.06.20164848 SP - 2020.08.06.20164848 AU - Eleni Syrimi AU - Eanna Fennell AU - Alex Richter AU - Pavle Vrljicak AU - Richard Stark AU - Sascha Ott AU - Paul G Murray AU - Eslam Al-Abadi AU - Ashish Chikermane AU - Pamela Dawson AU - Scott Hackett AU - Steven Welch AU - Deepthi Jyothish AU - Hari Krishnan Kanthimathinathan AU - Sean Monaghan AU - Prasad Nagakumar AU - Barnaby R Scholefield AU - Pamela Kearns AU - Graham S Taylor Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/07/2020.08.06.20164848.abstract N2 - Paediatric inflammatory multisystem inflammatory syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) is a new disease with overlapping features of Kawasaki disease (KD) and toxic shock syndrome. Unbiased single cell RNA sequencing analysis of peripheral blood mononuclear cells from PIMS-TS and KD patients shows monocytes are the main source of pro-inflammatory cytokines and large changes in the frequency of classical, intermediate and non-classical monocytes occur in both diseases.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is not a clinical trial. Ethical approval has been obtained to perform this study in accordance with the Declaration of Helsinski.Funding StatementBirmingham Womens and Childrens Hospital Charity funded the single cell RNA sequencing analysis. ES is supported by a CRUK Birmingham Centre clinical PhD fellowship. BS is funded by a National Institute for Health Research (NIHR) Clinician Scientist fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by South of Birmingham Research Ethics Committee (REC: 17/WM/0453, IRAS: 233593). Written informed consent was obtained from all participants or their legal guardians.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRNAseq data will be available upon article acceptance. ER -